Gelstat Corp
OTC:GSAC

Watchlist Manager
Gelstat Corp Logo
Gelstat Corp
OTC:GSAC
Watchlist
Price: 0.0003 USD Market Closed
Market Cap: 1.1m USD

ROE
Return on Equity

-26.5%
Current
-24%
Average
2.8%
Industry

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
-26.5%
=
Net Income
-1.2m
/
Equity
5.4m

ROE Across Competitors

No Stocks Found

Gelstat Corp
Glance View

Market Cap
1.1m USD
Industry
Pharmaceuticals

GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Stuart, Florida. The firm is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The firm offers various products, which include GelStat Migraine and GelStat Sleep. GelStat Migraine is a solution designed for the pain relief from migraine headaches. GelStat Migraine is a formulation based on the medicinal plant’s feverfew (tanacetum parthenium) and ginger (zingiber officinale). Feverfew and ginger contain various compounds, including sesquiterpene lactones and flavonoids. GelStat Sleep provides relief from sleep disorders and its associated symptoms.

GSAC Intrinsic Value
Not Available
What is Return on Equity?

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
-26.5%
=
Net Income
-1.2m
/
Equity
5.4m
What is the ROE of Gelstat Corp?

Based on Gelstat Corp's most recent financial statements, the company has ROE of -26.5%.

Back to Top